求以下文章的全文，请XDJM们帮忙。多谢！！# Immigration - 落地生根
s*l
1 楼
1. Semin Nephrol. 2014 Mar;34(2):135-50. doi: 10.1016/j.semnephrol.2014.
02.006. Epub 2014 Feb 18.
Gases as uremic toxins: is there something in the air?
Jankowski J1, Westhof T2, Vaziri ND3, Ingrosso D4, Perna AF5.
2. Future Microbiol. 2014 Mar;9(3):399-410. doi: 10.2217/fmb.13.165.Role
of altered intestinal microbiota in systemic inflammation and cardiovascular
disease in chronic kidney disease.Mafra D1, Lobo JC, Barros AF, Koppe L,
Vaziri ND, Fouque D.
3. Expert Opin Drug Metab Toxicol. 2014 Aug;10(8):1131-43. doi: 10.1517/
17425255.2014.931371. Epub 2014 Jun 24. Pharmacokinetic considerations in
chronic kidney disease and patients requiring dialysis.
Velenosi TJ1, Urquhart BL.
4. Inflamm Allergy Drug Targets. 2009 Mar;8(1):40-52.
The IL-12 family of cytokines in infection, inflammation and autoimmune
disorders. Gee K1, Guzzo C, Che Mat NF, Ma W, Kumar A.
5. Adv Immunol. 2008;99:115-63. doi: 10.1016/S0065-2776(08)00605-6.
Emergence of the Th17 pathway and its role in host defense. O'Quinn DB1,
Palmer MT, Lee YK, Weaver CT.
6. Int J Mol Med. 2008 Aug;22(2):181-5.Bifidobacterium infantis
suppresses proinflammatory interleukin-17 production in murine splenocytes
and dextran sodium sulfate-induced intestinal inflammation.
7. J Investig Med. 2010 Oct;58(7):905-8. doi: 10.231/JIM.0b013e3181eb9895
. Infliximab reduces the frequency of interleukin 17-producing cells and the
amounts of interleukin 17 in patients with rheumatoid arthritis. Shen H1,
Xia L, Lu J, Xiao W.
8. Scand J Gastroenterol. 2012 Oct;47(10):1200-10. Epub 2012 Aug 6. The
effect of adalimumab for induction of endoscopic healing and normalization
of mucosal cytokine gene expression in Crohn's disease. Rismo R1, Olsen T,
Ciu G, Paulssen EJ, Christiansen I, Florholmen J, Goll R.
9. Inflamm Bowel Dis. 2013 Feb;19(2):246-53. doi: 10.1002/ibd.23023.
Neutralization of membrane TNF, but not soluble TNF, is crucial for the
treatment of experimental colitis. Perrier C1, de Hertogh G, Cremer J,
Vermeire S, Rutgeerts P, Van Assche G, Szymkowski DE, Ceuppens JL.
10. Scand J Gastroenterol. 2013 Mar;48(3):311-9. doi: 10.3109/00365521.
2012.758773. Epub 2013 Jan 10. Normalization of mucosal cytokine gene
expression levels predicts long-term remission after discontinuation of anti
-TNF therapy in Crohn's disease. Rismo R1, Olsen T, Cui G, Paulssen EJ,
Christiansen I, Johnsen K, Florholmen J, Goll R.
02.006. Epub 2014 Feb 18.
Gases as uremic toxins: is there something in the air?
Jankowski J1, Westhof T2, Vaziri ND3, Ingrosso D4, Perna AF5.
2. Future Microbiol. 2014 Mar;9(3):399-410. doi: 10.2217/fmb.13.165.Role
of altered intestinal microbiota in systemic inflammation and cardiovascular
disease in chronic kidney disease.Mafra D1, Lobo JC, Barros AF, Koppe L,
Vaziri ND, Fouque D.
3. Expert Opin Drug Metab Toxicol. 2014 Aug;10(8):1131-43. doi: 10.1517/
17425255.2014.931371. Epub 2014 Jun 24. Pharmacokinetic considerations in
chronic kidney disease and patients requiring dialysis.
Velenosi TJ1, Urquhart BL.
4. Inflamm Allergy Drug Targets. 2009 Mar;8(1):40-52.
The IL-12 family of cytokines in infection, inflammation and autoimmune
disorders. Gee K1, Guzzo C, Che Mat NF, Ma W, Kumar A.
5. Adv Immunol. 2008;99:115-63. doi: 10.1016/S0065-2776(08)00605-6.
Emergence of the Th17 pathway and its role in host defense. O'Quinn DB1,
Palmer MT, Lee YK, Weaver CT.
6. Int J Mol Med. 2008 Aug;22(2):181-5.Bifidobacterium infantis
suppresses proinflammatory interleukin-17 production in murine splenocytes
and dextran sodium sulfate-induced intestinal inflammation.
7. J Investig Med. 2010 Oct;58(7):905-8. doi: 10.231/JIM.0b013e3181eb9895
. Infliximab reduces the frequency of interleukin 17-producing cells and the
amounts of interleukin 17 in patients with rheumatoid arthritis. Shen H1,
Xia L, Lu J, Xiao W.
8. Scand J Gastroenterol. 2012 Oct;47(10):1200-10. Epub 2012 Aug 6. The
effect of adalimumab for induction of endoscopic healing and normalization
of mucosal cytokine gene expression in Crohn's disease. Rismo R1, Olsen T,
Ciu G, Paulssen EJ, Christiansen I, Florholmen J, Goll R.
9. Inflamm Bowel Dis. 2013 Feb;19(2):246-53. doi: 10.1002/ibd.23023.
Neutralization of membrane TNF, but not soluble TNF, is crucial for the
treatment of experimental colitis. Perrier C1, de Hertogh G, Cremer J,
Vermeire S, Rutgeerts P, Van Assche G, Szymkowski DE, Ceuppens JL.
10. Scand J Gastroenterol. 2013 Mar;48(3):311-9. doi: 10.3109/00365521.
2012.758773. Epub 2013 Jan 10. Normalization of mucosal cytokine gene
expression levels predicts long-term remission after discontinuation of anti
-TNF therapy in Crohn's disease. Rismo R1, Olsen T, Cui G, Paulssen EJ,
Christiansen I, Johnsen K, Florholmen J, Goll R.